Suchergebnisse - "Izadifar, Armine"
-
1
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.07.2020Veröffentlicht in The European respiratory journal (01.07.2020)Weitere Angaben
Journal Article -
2
Tuberculosis and COVID-19 co-infection: description of the global cohort
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.03.2022Veröffentlicht in The European respiratory journal (01.03.2022)“… Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is still limited. The aim of this study was to describe the features of the …”
Weitere Angaben
Journal Article -
3
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
ISSN: 2213-2619, 2213-2619Veröffentlicht: 01.07.2020Veröffentlicht in The lancet respiratory medicine (01.07.2020)“… Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Blood signatures might act as a standalone screening tool, …”
Weitere Angaben
Journal Article -
4
Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A). Short version
ISSN: 2590-0412, 2590-0412Veröffentlicht: France Elsevier Masson SAS 01.05.2022Veröffentlicht in Respiratory medicine and research (01.05.2022)“… The therapeutic management strategy is based on the regular evaluation of the control of asthmatic disease, with an effective minimum dose research and the …”
Volltext
Journal Article -
5
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial
ISSN: 1399-3003, 1399-3003Veröffentlicht: England 01.10.2018Veröffentlicht in The European respiratory journal (01.10.2018)“… The anti-tumour and anti-metastatic properties of heparins have not been tested in patients with early stage cancer. Whether adjuvant low molecular weight …”
Weitere Angaben
Journal Article -
6
Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
ISSN: 0091-6749, 1097-6825, 1097-6825Veröffentlicht: United States Elsevier Inc 01.10.2024Veröffentlicht in Journal of allergy and clinical immunology (01.10.2024)“… [Display omitted] Switching biologics is now common practice in severe eosinophilic asthma. After insufficient response to anti–IL-5 or 5 receptor …”
Volltext
Journal Article -
7
Self-reported asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey
ISSN: 2590-0412, 2590-0412Veröffentlicht: France Elsevier Masson SAS 01.11.2021Veröffentlicht in Respiratory medicine and research (01.11.2021)“… There is a paucity of epidemiological data on asthma classified by disease severity in France. The ASTHMAPOP cross-sectional study aimed to review the …”
Volltext
Journal Article